Comparison of therapeutic, immunity and efficacy of topical hydrogen peroxide solution (40% vol) with cryotherapy in seborheic keratosis.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220117053747N2

Enrollment

Registered

2022-03-25

Start date

2022-01-22

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Seborrheic keratosis. Seborrheic keratosis

Interventions

Intervention 1: Intervention group: Patients in the intervention group will receive topical hydrogen peroxide solution (40% by volume). The solution will be applied to the lesion so that it covers the

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age over 18 years Patient with definite diagnosis of seborrheic keratosis according to diagnostic criteria (Existence of at least one separate lesion in the trunk or limbs with a depth of 0 to 2 mm and length and width of 5 to 15 mm) Existence of at least 4 lesions of seborrheic keratosis in the individual Satisfaction to participate in the study

Exclusion criteria

Exclusion criteria: Presence of the lesion at the site of hair growth (so that the medicine does not reach the lesion well) Presence of a lesion on the eyelid Lesions at a distance of 5 mm from the eye

Design outcomes

Primary

Measure	Time frame
The effectiveness of the treatment will be assessed by the Physician's Lesion Assessment Scale (PLA). The scoring of this scale is 4 numbers (0 = no lesion; 1 = almost no lesion; = Lesions with a depth of more than 1 mm) Patients will be evaluated by this scale at the time of the first visit, 3 weeks later, 6 weeks later and 8 weeks after receiving the treatment. will be. Timepoint: Physician’s lesion assesment scale measurement at the time of the first visit, 3 weeks later, 6 weeks later and 8 weeks after receiving treatment. Method of measurement: Physician’s lesion assesment scale score.	—

Measure

Time frame

The effectiveness of the treatment will be assessed by the Physician's Lesion Assessment Scale (PLA). The scoring of this scale is 4 numbers (0 = no lesion; 1 = almost no lesion; = Lesions with a depth of more than 1 mm) Patients will be evaluated by this scale at the time of the first visit, 3 weeks later, 6 weeks later and 8 weeks after receiving the treatment. will be. Timepoint: Physician’s lesion assesment scale measurement at the time of the first visit, 3 weeks later, 6 weeks later and 8 weeks after receiving treatment. Method of measurement: Physician’s lesion assesment scale score.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactArmaghan Gharehaghajizare

Tabriz University of Medical Sciences

Ghareaghajia@tbmed.ac.ir+98 41 3549 8236

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026